Managers / Q1 2021 · view latest →
Global Frontier Investments LLC
CIK 0001821219 · 92 BROAD STREET, CHARLESTON, SC, 29401 · 4154020285
Summary
Global Frontier Investments LLC reported $116M in U.S.-listed holdings across 18 positions for Q1 2021.
The portfolio is heavily concentrated: JPM alone accounts for 32.1% of reported value.
Compared with Q4 2020, the fund opened 0 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 98.5% · $114M
- Other · 1.5% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| OXFORD IMMUNOTEC GLOBAL PLC | SOLD OUT | −272.3K | 0 | −$5M | $0 |
| JPMJPMORGAN CHASE | HELD | +0 | 245.0K | +$6M | $37M |
| WALWESTERN ALLIANCE BANCORP | HELD | +0 | 120.0K | +$4M | $11M |
| BRK/ABERKSHIRE HATHAWAY INC CL A | HELD | +0 | 33 | +$1M | $13M |
| OZKBANK OZK | HELD | +0 | 125.0K | +$1M | $5M |
| GSGOLDMAN SACHS GROUP INC | HELD | +0 | 15.0K | +$949,000 | $5M |
| KKRKKR | HELD | +0 | 100.0K | +$836,000 | $5M |
| WFCWELLS FARGO | HELD | +0 | 70.0K | +$622,000 | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | JPMJPMORGAN CHASEhistory → | COMMON EQUITY | 32.13% | $37M | 245.0K |
| 2 | BRK/ABERKSHIRE HATHAWAY INC CL Ahistory → | COMMON EQUITY | 10.97% | $13M | 33 |
| 3 | WALWESTERN ALLIANCE BANCORPhistory → | COMMON EQUITY | 9.76% | $11M | 120.0K |
| 4 | ACGLARCH CAPITAL GROUP LTDhistory → | COMMON EQUITY | 4.96% | $6M | 150.0K |
| 5 | OZKBANK OZKhistory → | COMMON EQUITY | 4.40% | $5M | 125.0K |
| 6 | GSGOLDMAN SACHS GROUP INChistory → | COMMON EQUITY | 4.23% | $5M | 15.0K |
| 7 | KKRKKRhistory → | COMMON EQUITY | 4.21% | $5M | 100.0K |
| 8 | PGRPROGRESSIVE CORPhistory → | COMMON EQUITY | 3.71% | $4M | 45.0K |
| 9 | ACNACCENTURE PLC CL Ahistory → | COMMON EQUITY | 3.57% | $4M | 15.0K |
| 10 | CADENCE BANCORP | COMMON EQUITY | 3.54% | $4M | 250.0K |
| 11 | CCITIGROUP INChistory → | COMMON EQUITY | 3.13% | $4M | 50.0K |
| 12 | AXPAMERICAN EXPRESS COhistory → | COMMON EQUITY | 3.05% | $4M | 25.0K |
| 13 | AONAON PLC CLASS Ahistory → | COMMON EQUITY | 2.97% | $3M | 15.0K |
| 14 | SCHWSCHWAB (CHARLES) CORPhistory → | COMMON EQUITY | 2.81% | $3M | 50.0K |
| 15 | NTRSNORTHERN TRUST CORPhistory → | COMMON EQUITY | 2.72% | $3M | 30.0K |
| 16 | WFCWELLS FARGOhistory → | COMMON EQUITY | 2.36% | $3M | 70.0K |
| 17 | AMRYT PHARMA LTD - SPNR ADR | COMMON EQUITY | 1.50% | $2M | 125.0K |
| 18 | OXFORD IMMUNOTEC GLOBAL PLC | COMMON EQUITY | 0.00% | $0 | 0 |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026REVEALED | $1.2B | 53 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $507M | 23 | Feb 18, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $519M | 23 | Nov 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $419M | 23 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $389M | 23 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $335M | 23 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $341M | 23 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $231M | 23 | Dec 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $228M | 23 | Aug 16, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $223M | 23 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $227M | 23 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $197M | 23 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $215M | 23 | Aug 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $259M | 23 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $265M | 22 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $137M | 19 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $132M | 18 | Aug 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $116M | 18 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $103M | 18 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $68M | 17 | Nov 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $66M | 16 | Aug 17, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.